1.
Emerg Infect Dis
; 27(2): 663-666, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33496647
RESUMO
Antibody response against nucleocapsid and spike proteins of SARS-CoV-2 in 11 persons with mild or asymptomatic infection rapidly increased after infection. At weeks 18-30 after diagnosis, all remained seropositive but spike protein-targeting antibody titers declined. These data may be useful for vaccine development.